
|Articles|October 1, 2004
Promising approaches to melanoma therapy
New York - While cytokines are currently standard therapy for advanced melanoma, cancer vaccines in advanced stages of development could soon change the treatment paradigm, says Howard L. Kaufman, M.D., speaking at the American Academy of Dermatology Academy '04 meeting here recently.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















